Pfizer, Inc. (NYSE:PFE) Valuation According To Analysts

Parkside Commercial Bank Tru holds 0.21% in Monsanto Company (NYSE:MON) or 4,413 shares. Tracking most recent quarter period, Price to book (P/B) ration is at 3.68 and Price to cash per share ration is at 14.96. The stock has been active on the tape, now trading at $36.14, up from yesterday's close by 0.25%. For PFE, the company now has $2.59 Billion of cash on the books, which is offset by $9.51 Billion current liabilities. It has underperformed by 19.46% the S&P500. Its down 36.9% from 139,300 shares previously. About 5.85M shares traded. Shareholders of record on Friday, November 10th will be paid a dividend of $0.32 per share. It has underperformed by 16.70% the S&P500. The Company is engaged in the discovery, development and manufacture of healthcare products. It now has negative earnings. It tells an investor how quickly a company is increasing its revenues. Its down 0.21, from 1.09 in 2017Q1. It also increased its holding in Square Inc A by 293,137 shares in the quarter, for a total of 395,757 shares, and has risen its stake in Mylan Nv (NASDAQ:MYL). 73 funds opened positions while 252 raised stakes. Loomis Sayles And Ltd Partnership reported 22 shares. Equitec Proprietary Markets Limited Liability Com holds 65,900 shares. A total of 0.95 million shares exchanged at hands and its average trading volume is standing at 1.42 million shares. Shares of BHGE have sank -1.88% in the past three monthswhile the S&P 500 has dropped -8.33% in that time. Carret Asset Mgmt Ltd Llc, a New York-based fund reported 119,500 shares. Wells Fargo & Mn stated it has 0% in Technical Communications Corporation (NASDAQ:TCCO). It also upped Centene Corp (NYSE:CNC) stake by 12,643 shares and now owns 17,304 shares.

The good news is there's still room for Pfizer Inc. (NYSE:PFE) to report $0.64 EPS on November, 7.They anticipate $0.03 EPS change or 4.92 % from last quarter's $0.61 EPS. The biopharmaceutical company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.02. PFE's profit would be $3.81 billion giving it 14.11 P/E if the $0.64 EPS is correct.

Following previous thoughts, shifting focus on performance of the Pfizer Inc. The other 13, though not evenly; between analysts who think you should buy Pfizer Inc. versus those who think you should sell it. Therefore 55% are positive. PFE was included in 58 notes of analysts from July 29, 2015. The rating was downgraded by Credit Suisse to "Neutral" on Thursday, July 20. Argus Research maintained Pfizer Inc. (NYSE:PFE) on Monday, August 14 with "Buy" rating. (NYSE:PFE) on Thursday, August 4 with "Buy" rating.

Pfizer, Inc. has a 52-week low of $29.83 and a 52-week high of $36.24. The stock has a consensus rating of "Hold" and a consensus price target of $38.21. The company was maintained on Monday, April 18 by Goldman Sachs. Cowen & Co upgraded it to "Outperform" rating and $43 target in Tuesday, October 20 report.

Pfizer Inc (NYSE:PFE) institutional sentiment decreased to 0.94 in 2017 Q2. Its down 0.01, from 0.95 in 2017Q1. 91 funds opened positions while 275 raised stakes. The California-based Laurel Grove Cap Ltd Liability has invested 0.28% in Morgan Stanley (NYSE:MS). Cubist Systematic Strategies Limited Liability reported 160,244 shares or 0.46% of all its holdings. Utd Fire Grp Incorporated owns 40,000 shares or 0.48% of their U.S. portfolio. On Monday, May 2 the stock rating was maintained by Leerink Swann with "Market Perform". Train Babcock Advsr Limited Liability Co has 12,410 shares for 0.18% of their portfolio.

Baker Hughes, a GE company (BHGE) pulled off a 0.14 percent gain and now trades for $36.53. Zeke Advsr Lc reported 0.5% in Pfizer Inc. (NYSE:PFE) for 393,488 shares.

Analysts expect Pfizer Inc. That suggests something of the likelihood of a short squeeze in shares of PFE. Bahl And Gaynor holds 1.46% in Pfizer Inc. Salient Cap Ltd Llc, Texas-based fund reported 58,121 shares. Monetary Mgmt Grp Inc Incorporated holds 0.38% or 27,345 shares. The original version of this piece can be viewed at

Receive Pfizer, Inc. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pfizer, Inc. with's FREE daily email newsletter.